Yueh-Yi Chiang, Susan dosReis, Charmaine Rochester-Eyeguokan, Eberechukwu Onukwugha. Comorbid Depression and Anxiety and Their Association with Healthcare Resource Utilization among Individuals with Type 1 Diabetes in the United States. Journal of Managed Care & Specialty Pharmacy (JMCP). 2024
Ebony I Evans, PharmD. Kathleen J Pincus, Hyunuk Seung, MS; Charmaine D. Rochester-Eyeguokan. Health Literacy of Patients Using Continuous Glucose Monitoring. AJHP 2024.
Current Recommendations for Insulin Therapy in the Hospitalized Patient. Charmaine Rochester-Eyeguokan, Kathleen Pincus. CCNJ 2024.
Sade Osotimehin, Olufunke Sokan, Byron Ma, Hyunuk Seung, Charmaine Rochester, Magaly Rodriguez de Bittner. Pharmacists’ reducing health disparities in the management of hypertension through remote patient monitoring. FIP 2024.
Solanke A, Rochester-Eyeguokan CD, Pincus KJ, Azikiwe I. Impact of a Clinical Pharmacist-Led Comprehensive Diabetes Management Program (CDMP) on Diabetes Outcomes at a Federally Qualified Health Center (FQHC). ASHP Midyear. Poster Presentation. 2024.
Osotimehin F, Rodriguez de Bittner M, Rochester-Eyeguokan CD, et al. Interprofessional Telehealth Experience: Student Experiences and Reflections. National Academies of Practice (NAP) Abstract Subcommittee 2024.
Rochester-Eyeguokan CD, Patel D, Klutts A. Lower Gastrointestinal Disorders. Applied Therapeutics. The Clinical Use of Drugs. Twelfth Edition. Editors: Caroline Zeind. 2023.
Pamulapati-Grecheck L, Rochester CD, Pincus K. Updated best practice statements regarding sodium-glucose cotransporter-2 inhibitors and serum potassium levels. Response Letter. American Journal of Health Systems Pharmacy. March 2021. https://academic.oup.com/ajhp/advance-article-abstract/doi/10.1093/ajhp/zxab124/6188354
Pamulapati-Grecheck L, Rochester CD, Pincus K. Best practices for safe use of SGLT-2 inhibitors developed from an expert panel Delphi consensus process. American Journal of Health Systems Pharmacy. July 2020. 77(21):1727038. https://doi.org/10.1093/ajhp/zxaa243
Solinsky Paul, Rochester CD, Brandt N, Pincus K. A Multicenter Focus Group Analysis of Medicare Beneficiaries Medicare Perception of Annual Wellness Visits. Journal for Healthcare Quality. June 22, 2020. doi:10.1097/JHQ.0000000000000273.
Rochester-Eyeguokan CD, Meade L. A Practical Approach to Managing Hypoactive Sexual Desire Disorder (HSDD) in Women with Diabetes. Diabetes Therapy: Research, Treatment, and Education of Diabetes and Related Disorders 2017 September 16. http://sumo.ly/GZ8L via @QxMD.
Tofade T, Laliberte B, Rochester-Eyeguokan CD. Lower Gastrointestinal Disorders. Applied Therapeutics. The Clinical Use of Drugs. Eleven Edition. Editors: Caroline Zeind. December 2017.
Rochester-Eyeguokan CD, Patel R. New Pharmacotherapies for Type 2 Diabetes. PSAP 2017 Book 1. Endocrinology/Nephrology Module. 2017;29-57.
Haines ST, Miklich MA*, Rochester-Eyeguokan CD. Best Practices for the safe use of Insulin Pen devices in Hospitals: recommendations from an expert panel Delphi consensus. Am J Health-Syst Pharm. 2016; 73(suppl 5):S4-16. DOI: 10.2146/ajhp080706. Original Research.
Rochester-Eyeguokan CD, Pincus KJ, Patel RS, Reitz SJ. The Current Landscape of Transitions of Care Practice Models: A Scoping Review. Pharmacotherapy 2016; 36(1):117-33. doi 10.1002/phar.1685. Review.
Shaya F, Chirikov V, Rochester C, Zaghab R, Kucharski K. Impact of a comprehensive pharmacist medication-therapy management service. Journal of Medical Economics 2015;18(10):1-28. doi:10.3111/13696998.2015.1052463. Original Research.
Hadley DE*, Lebovitz L, Huynh D, Rochester CD. Evaluation of Third-Year Doctor of Pharmacy Students’ Attitudes, Perceptions, and Behaviors on their Elective Decisions. Pharmacy Education 2014;14(1):124-8. Original Research.
Rochester CD, Akiyode O. Novel, and emerging diabetes mellitus drug therapies for the type 2 diabetes patient. World J Diabetes 2014;5(3):305-15. http://dx.doi. org/10.4239/wjd.v5.i3.30.
Havrda DE, Engle JP, Anderson KC, Ray SM, Haines SL, Kane-Gill SL, Ballard SL, Crannage AJ, Rochester CD, Parman MG. Guidelines for Resident Teaching Experiences. Pharmacotherapy 2013;33(7):e147-61. doi: 10.1002/phar.1250. White Paper.
Ionica N*, Sourwine M*, Rochester CD, Steinle NI. Vitamin B12: Considerations for Maintaining Optimum Health in Elders. Clinical Geriatrics 2012;20(1):22-7. Review.
Sareh P*, Sourwine M*, Rochester CD, Steinle NI. Vitamin D and Calcium: Implications for Healthy Aging. Clinical Geriatrics 2011;19(12):29-34. Review.
Deyo Z*, Huynh D, Rochester CD, Sturpe DA, Kiser K. Readiness for Self-directed Learning and Academic Performance in an Abilities Laboratory Course. American Journal of Pharmaceutical Education 2011:75(2):25. Original Research.
Bakshai J*, Bleu-Laine R*, Jung M*, Lim J*, Reyes C*, Sun L*, Rochester C, Shaya FT. The Cost Effectiveness and Budget Impact of Natalizumab for Formulary Inclusion. J Med Econ. 2010;13(1):63-9 doi: 10.3111/13696990903543424. Review.
Rochester CD, Leon N*, Dombrowski R, Haines ST. Collaborative Drug Therapy Management for Initiating and Titrating Insulin Therapy in Patients with Type 2 Diabetes. Am. J. Health Syst. Pharm. 2010;67(1):42-8 doi: 10.2146/ajhp080706. Original Research.
Hemstreet B, Rochester CD. Women’s Health Across the Lifespan: A Pharmacotherapeutic Approach. Chapter 33: Gastrointestinal Disorders. Editor: Borgett. 2010;511-32. Citations 12: ISI Web Knowledge/Google Scholar.
Lounsbery JL*, Rochester CD, Sturpe DA. Evaluation of Student Pharmacists’ Perceptions of Skills and Attitudes to Provide Medication Therapy Management Services. IJPEP 2008;4(2):1-16. Original Research.
Rochester CD, Pradel F. Students Perception and Satisfaction with a Web-Based Human Nutrition Course. American Journal of Pharmaceutical Education 2008;72(4):1-7. Original Research.
Rochester CD. Irritable Bowel Syndrome: Is the Treatment Different for Women? Maryland Pharmacist Journal 2008;84(1):7-9. Review.
Rochester CD. The Role of Incretin Mimetics in the Treatment of Type 2 Diabetes. US Pharmacist 2007;32(6):84-93. Review.
Rochester CD. Drug Interactions in Dermatology: Are They Just Skin Deep? US Pharmacist. 2007;32(4):HS29-39. Review.
Rochester CD, Cooke CE. The Changing Face of Dyslipidemia Therapies. Journal of Pharmacy Practice. 2006;19(2):79-93. doi: 10.1177/0897190006290137. Review.
Samuel J*, Rochester CD. Combination Agents for Diabetes. Adv Nurse Pract 2003; 11(6):22-4. Review.
Noble SL, Rochester CD. Asthma Management in Young Children. Drug Topics 1998; 142(Mar 2);1-19. Review.
Rochester CD, Noble SL. Choosing Treatment Options for Patients with Asthma. Drug Topics 1997;141(22);74-83. Review.